NueHealth, GeneNews agree to three-year deal to improve screening for colorectal, lung, prostate cancer
NueHealth and advanced diagnostics company GeneNews entered a three-year partnership to improve early cancer screening by offering tests for colorectal, lung, and prostate cancer to patients within NueHealth’s care network. Under the agreement, patients can access multiple GeneNews-developed screening tests through NueHealth facilities, with samples sent to GeneNews labs for analysis. The collaboration aims to enhance preventive care and support better adherence to cancer screening, potentially lowering costs and improving outcomes.